Wanlong Ma

NeoGenomics Laboratories

Research Area

Biography

Wanlong Ma has not added Biography.
If you are Wanlong Ma and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2017

Other Publications

Article	Year
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia. Haematologica\| PubMed ID: 17296565	2007
Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status. British journal of haematology\| PubMed ID: 17868045	2007
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 18224667	2008
Higher detection rate of JAK2 mutation using plasma. Blood\| PubMed ID: 18362222	2008
BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations. Molecular cancer therapeutics\| PubMed ID: 19056677	2008
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. The Journal of molecular diagnostics : JMD\| PubMed ID: 19074595	2009
Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations. Cancer\| PubMed ID: 19195039	2009
B-cell clones as early markers for chronic lymphocytic leukemia. The New England journal of medicine\| PubMed ID: 19213679	2009
K-ras mutations and cetuximab in colorectal cancer. The New England journal of medicine\| PubMed ID: 19238675	2009
Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications. Cancer biomarkers : section A of Disease markers\| PubMed ID: 19242062	2009
BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors. Acta haematologica\| PubMed ID: 19332983	2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19458051	2009
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia. Leukemia research\| PubMed ID: 19679351	2010
Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations. BMC structural biology\| PubMed ID: 19744331	2009
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leukemia research\| PubMed ID: 20362333	2010
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms. PloS one\| PubMed ID: 20730051	2010
Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance. Leukemia research\| PubMed ID: 20951430	2011
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome. BMC medical genetics\| PubMed ID: 21078205	2010
MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 21326037	2011
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. Journal of gastroenterology and hepatology\| PubMed ID: 21418304	2011
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling. PloS one\| PubMed ID: 21858098	2011
BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease. Molecular cytogenetics\| PubMed ID: 22549126	2012
Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b. Neurological research\| PubMed ID: 22709658	2012
Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers. Genetic testing and molecular biomarkers\| PubMed ID: 24512523	2014
Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer. Journal of Cancer\| PubMed ID: 25874003	2015
Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System. Journal of Cancer\| PubMed ID: 26918043	2016
Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome. Genetic testing and molecular biomarkers\| PubMed ID: 27248906	2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leukemia research\| PubMed ID: 27658269	2016
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors... Oncotarget\| PubMed ID: 28212557	2017